MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $418 | -47.5% | 2,859 | -17.0% | 0.00% | -40.0% |
| Q2 2023 | $796 | -11.0% | 3,445 | -6.6% | 0.01% | -16.7% |
| Q1 2023 | $894 | -14.1% | 3,689 | +2.9% | 0.01% | -25.0% |
| Q4 2022 | $1,041 | -99.6% | 3,586 | -8.3% | 0.01% | +300.0% |
| Q3 2022 | $254,000 | +21.5% | 3,909 | +83.5% | 0.00% | +100.0% |
| Q1 2022 | $209,000 | -47.8% | 2,130 | +48.8% | 0.00% | -66.7% |
| Q2 2018 | $400,000 | – | 1,431 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 463,000 | $99,142,000 | 4.55% |
| Rock Springs Capital Management LP | 342,000 | $73,232,000 | 2.65% |
| ACUTA CAPITAL PARTNERS, LLC | 33,000 | $7,066,000 | 2.52% |
| HealthCor Management, L.P. | 262,860 | $56,286,000 | 1.87% |
| Baker Brothers Advisors | 1,169,278 | $250,377,000 | 1.65% |
| EMORY UNIVERSITY | 11,391 | $2,439,000 | 1.60% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 8,690 | $1,862,000 | 1.48% |
| GREAT POINT PARTNERS LLC | 40,400 | $8,651,000 | 1.35% |
| SHIKIAR ASSET MANAGEMENT INC | 15,341 | $3,285,000 | 1.28% |
| ARMISTICE CAPITAL, LLC | 80,000 | $17,130,000 | 1.03% |